Free shipping on all orders over $ 500

XL888

Cat. No. M2070

All AbMole products are for research use only, cannot be used for human consumption.

XL888 Structure
Size Price Availability Quantity
10mg USD 240  USD240 In stock
25mg USD 460  USD460 In stock
50mg USD 840  USD840 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

XL888 is an orally bioavailable, ATP-competitive HSP90 inhibitor with potential antineoplastic activity. XL888 specifically binds to Hsp90, inhibiting its chaperone function and promoting the proteasomal degradation of oncogenic signaling proteins involved in tumor cell proliferation and survival. XL888 potently inhibited cell growth, induced apoptosis, and prevented the growth of vemurafenib-resistant melanoma cell lines in vitro and in vivo. XL888 (100 mg/kg) significantly induces the regression or growth inhibition (50%) of established M229R and 1205LuR xenografts in SCID mice. XL888 treatment increased BIM expression, decreased Mcl-1 expression, and induced apoptosis more effectively than dual mitogen-activated protein-extracellular signal-regulated kinase/phosphoinositide 3-kinase (MEK/PI3K) inhibition.

Protocol (for reference only)
Cell Experiment
Cell lines vemurafenib naïve and resistant melanoma cell lines and melanoma cell lines
Preparation method Growth inhibition.
Cells were plated at a density of 2.5 × 104 cells per ml and left to grow overnight before being treated with increasing concentrations of vemurafenib or XL888 as described in (19). Data show the mean of at least three independent experiments ± the S.E. mean.
Concentrations 1nM ~ 10 µM
Incubation time 72 h
Animal Experiment
Animal models BALB SCID mice bearing Xenograft experiments
Formulation 10mM HCl
Dosages 100 mg/kg 3x per week
Administration oral gavage
Chemical Information
Molecular Weight 503.64
Formula C29H37N5O3
CAS Number 1149705-71-4
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Bussenius J, et al. Bioorg Med Chem Lett. Discovery of XL888: a novel tropane-derived small molecule inhibitor of HSP90.

[2] Paraiso KH, et al. Clin Cancer Res. The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms.

Related HSP Products
NCT-58 

NCT-58 is a potent inhibitor of C-terminal HSP90.

Gedunin 

Gedunin is a limonoid with anti-cancer, anti-viral, anti-inflammatory and insecticidal activities.

VER-49009

VER-49009 is a Hsp90 inhibitor, with an IC50 of 25 nM and a Kd of 78 nM.

YUM70

YUM70 is a potent and selective inhibitor of glucose-regulated protein 78 (GRP78), with an IC50 of 1.5 μM for inhibiting GRP78 ATPase activity. YUM70 induces endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer.

Hsp70-derived octapeptide

Hsp70-derived octapeptide is a conserved octapeptide of the C-terminal end of Hsp70, which physically interacts with tetratricopeptide repeat (TPR) motifs.

  Catalog
Abmole Inhibitor Catalog




Keywords: XL888 supplier, HSP, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.